Paul A. Friedman
Chief Executive Officer, Incyte.
Companies
- Prelude Therapeutics IncBoard member Sep 24, 2020 to now1
- MADRIGAL PHARMACEUTICALS, INC.Board member Mar 5, 2014 to now2
- MADRIGAL PHARMACEUTICALS, INC.Chief executive officer Jul 26, 2016 to Jan 18, 20233
- Alexion PharmaceuticalsBoard member Sep 22, 2017 to Jul 23, 20214
- IncyteBoard member Jan 17, 2006 to May 28, 20205
- Dare Bioscience, Inc.Board member Apr 10, 2014 to Apr 5, 20176
- Verastem OncologyBoard member May 13, 2014 to Jun 16, 20167
- IncyteChief executive officer Jan 17, 2006 to Dec 20, 20135
- Bausch & LombBoard member Sep 25, 2007 to Oct 30, 20078
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- MADRIGAL PHARMACEUTICALS, INC. MDGL842,704 shares9$375.1M at $445.11Jan 13, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 9, 2026Sold 40 shares at $545.79 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 600 shares at $540.36 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 480 shares at $539.23 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 80 shares at $537.85 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 487 shares at $536.88 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 473 shares at $536.02 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 148 shares at $535.29 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 332 shares at $534.16 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 80 shares at $532.50 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 280 shares at $530.69 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 166 shares at $529.76 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 691 shares at $529.17 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 575 shares at $528.18 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 1,560 shares at $526.97 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 1,066 shares at $526.00 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 2,432 shares at $525.05 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 1,199 shares at $524.10 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 970 shares at $523.00 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 840 shares at $521.98 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 681 shares at $521.03 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 846 shares at $519.88 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 1,363 shares at $518.68 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 2,450 shares at $517.86 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 766 shares at $516.84 of MADRIGAL PHARMACEUTICALS, INC.9
- Jan 9, 2026Sold 1,996 shares at $515.81 of MADRIGAL PHARMACEUTICALS, INC.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARIncyte, Board member
- 6SEC EDGARDare Bioscience, Inc., Board member
- 7SEC EDGARVerastem Oncology, Board member
- 8SEC EDGARBausch & Lomb, Board member
- 9